These experimental results underscore the critical role of HNRNPC in the progression of hepatocellular carcinoma and highlight its potential as a therapeutic target for liver cancer, particularly as a target for immunotherapy. This evidence concerns the gene HNRNPC and hepatocellular carcinoma.